The list price is not right: Trump’s plan to force pharma to advertise prices is misguided
The proposed rule to list drug prices in ads is likely to create confusion — and it lacks teeth.
Talk about a non-starter.
For months, the White House has promised action on rising drug prices, yet, so far, little has happened. Now, though, the administration is trumpeting a rule to force drug makers to disclose prices in TV ads.
The hope is that companies will be persuaded to compete on price if “relevant information” is provided for any drug that is available under Medicare or Medicaid, if the price is more than $35 a month.
The notion may be well-intended,
